|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 7/16/19 Cannex Capital Holdings Inc. 40FR12G 138:29M Newsfile Corp/FA |
Document/Exhibit Description Pages Size 1: 40FR12G Registration of Securities of a Canadian Issuer HTML 112K 2: EX-99.1 Miscellaneous Exhibit -- exhibit99-1 HTML 53K 11: EX-99.10 Miscellaneous Exhibit -- exhibit99-10 HTML 30K 101: EX-99.100 Miscellaneous Exhibit -- exhibit99-100 HTML 49K 102: EX-99.101 Miscellaneous Exhibit -- exhibit99-101 HTML 872K 103: EX-99.102 Miscellaneous Exhibit -- exhibit99-102 HTML 78K 104: EX-99.103 Miscellaneous Exhibit -- exhibit99-103 HTML 70K 105: EX-99.104 Miscellaneous Exhibit -- exhibit99-104 HTML 35K 106: EX-99.105 Miscellaneous Exhibit -- exhibit99-105 HTML 2.88M 107: EX-99.106 Miscellaneous Exhibit -- exhibit99-106 HTML 34K 108: EX-99.107 Miscellaneous Exhibit -- exhibit99-107 HTML 33K 109: EX-99.108 Miscellaneous Exhibit -- exhibit99-108 HTML 39K 110: EX-99.109 Miscellaneous Exhibit -- exhibit99-109 HTML 290K 12: EX-99.11 Miscellaneous Exhibit -- exhibit99-11 HTML 156K 111: EX-99.110 Miscellaneous Exhibit -- exhibit99-110 HTML 133K 112: EX-99.111 Miscellaneous Exhibit -- exhibit99-111 HTML 33K 113: EX-99.112 Miscellaneous Exhibit -- exhibit99-112 HTML 33K 114: EX-99.113 Miscellaneous Exhibit -- exhibit99-113 HTML 42K 115: EX-99.114 Miscellaneous Exhibit -- exhibit99-114 HTML 32K 116: EX-99.115 Miscellaneous Exhibit -- exhibit99-115 HTML 39K 117: EX-99.116 Miscellaneous Exhibit -- exhibit99-116 HTML 34K 118: EX-99.117 Miscellaneous Exhibit -- exhibit99-117 HTML 37K 119: EX-99.118 Miscellaneous Exhibit -- exhibit99-118 HTML 455K 120: EX-99.119 Miscellaneous Exhibit -- exhibit99-119 HTML 133K 13: EX-99.12 Miscellaneous Exhibit -- exhibit99-12 HTML 30K 121: EX-99.120 Miscellaneous Exhibit -- exhibit99-120 HTML 33K 122: EX-99.121 Miscellaneous Exhibit -- exhibit99-121 HTML 33K 123: EX-99.122 Miscellaneous Exhibit -- exhibit99-122 HTML 41K 124: EX-99.123 Miscellaneous Exhibit -- exhibit99-123 HTML 36K 125: EX-99.124 Miscellaneous Exhibit -- exhibit99-124 HTML 491K 126: EX-99.125 Miscellaneous Exhibit -- exhibit99-125 HTML 140K 127: EX-99.126 Miscellaneous Exhibit -- exhibit99-126 HTML 33K 128: EX-99.127 Miscellaneous Exhibit -- exhibit99-127 HTML 33K 129: EX-99.128 Miscellaneous Exhibit -- exhibit99-128 HTML 30K 130: EX-99.129 Miscellaneous Exhibit -- exhibit99-129 HTML 492K 14: EX-99.13 Miscellaneous Exhibit -- exhibit99-13 HTML 32K 131: EX-99.130 Miscellaneous Exhibit -- exhibit99-130 HTML 143K 132: EX-99.131 Miscellaneous Exhibit -- exhibit99-131 HTML 32K 133: EX-99.132 Miscellaneous Exhibit -- exhibit99-132 HTML 32K 134: EX-99.133 Miscellaneous Exhibit -- exhibit99-133 HTML 30K 135: EX-99.134 Miscellaneous Exhibit -- exhibit99-134 HTML 69K 136: EX-99.135 Miscellaneous Exhibit -- exhibit99-135 HTML 31K 137: EX-99.136 Miscellaneous Exhibit -- exhibit99-136 HTML 29K 138: EX-99.137 Miscellaneous Exhibit -- exhibit99-137 HTML 30K 15: EX-99.14 Miscellaneous Exhibit -- exhibit99-14 HTML 32K 16: EX-99.15 Miscellaneous Exhibit -- exhibit99-15 HTML 32K 17: EX-99.16 Miscellaneous Exhibit -- exhibit99-16 HTML 33K 18: EX-99.17 Miscellaneous Exhibit -- exhibit99-17 HTML 34K 19: EX-99.18 Miscellaneous Exhibit -- exhibit99-18 HTML 42K 20: EX-99.19 Miscellaneous Exhibit -- exhibit99-19 HTML 33K 3: EX-99.2 Miscellaneous Exhibit -- exhibit99-2 HTML 31K 21: EX-99.20 Miscellaneous Exhibit -- exhibit99-20 HTML 45K 22: EX-99.21 Miscellaneous Exhibit -- exhibit99-21 HTML 145K 23: EX-99.22 Miscellaneous Exhibit -- exhibit99-22 HTML 77K 24: EX-99.23 Miscellaneous Exhibit -- exhibit99-23 HTML 32K 25: EX-99.24 Miscellaneous Exhibit -- exhibit99-24 HTML 32K 26: EX-99.25 Miscellaneous Exhibit -- exhibit99-25 HTML 35K 27: EX-99.26 Miscellaneous Exhibit -- exhibit99-26 HTML 28K 28: EX-99.27 Miscellaneous Exhibit -- exhibit99-27 HTML 38K 29: EX-99.28 Miscellaneous Exhibit -- exhibit99-28 HTML 34K 30: EX-99.29 Miscellaneous Exhibit -- exhibit99-29 HTML 782K 4: EX-99.3 Miscellaneous Exhibit -- exhibit99-3 HTML 28K 31: EX-99.30 Miscellaneous Exhibit -- exhibit99-30 HTML 30K 32: EX-99.31 Miscellaneous Exhibit -- exhibit99-31 HTML 49K 33: EX-99.32 Miscellaneous Exhibit -- exhibit99-32 HTML 31K 34: EX-99.33 Miscellaneous Exhibit -- exhibit99-33 HTML 51K 35: EX-99.34 Miscellaneous Exhibit -- exhibit99-34 HTML 35K 36: EX-99.35 Miscellaneous Exhibit -- exhibit99-35 HTML 36K 37: EX-99.36 Miscellaneous Exhibit -- exhibit99-36 HTML 42K 38: EX-99.37 Miscellaneous Exhibit -- exhibit99-37 HTML 36K 39: EX-99.38 Miscellaneous Exhibit -- exhibit99-38 HTML 38K 40: EX-99.39 Miscellaneous Exhibit -- exhibit99-39 HTML 35K 5: EX-99.4 Miscellaneous Exhibit -- exhibit99-4 HTML 30K 41: EX-99.40 Miscellaneous Exhibit -- exhibit99-40 HTML 35K 42: EX-99.41 Miscellaneous Exhibit -- exhibit99-41 HTML 35K 43: EX-99.42 Miscellaneous Exhibit -- exhibit99-42 HTML 35K 44: EX-99.43 Miscellaneous Exhibit -- exhibit99-43 HTML 36K 45: EX-99.44 Miscellaneous Exhibit -- exhibit99-44 HTML 31K 46: EX-99.45 Miscellaneous Exhibit -- exhibit99-45 HTML 28K 47: EX-99.46 Miscellaneous Exhibit -- exhibit99-46 HTML 454K 48: EX-99.47 Miscellaneous Exhibit -- exhibit99-47 HTML 29K 49: EX-99.48 Miscellaneous Exhibit -- exhibit99-48 HTML 114K 50: EX-99.49 Miscellaneous Exhibit -- exhibit99-49 HTML 33K 6: EX-99.5 Miscellaneous Exhibit -- exhibit99-5 HTML 1.56M 51: EX-99.50 Miscellaneous Exhibit -- exhibit99-50 HTML 33K 52: EX-99.51 Miscellaneous Exhibit -- exhibit99-51 HTML 49K 53: EX-99.52 Miscellaneous Exhibit -- exhibit99-52 HTML 31K 54: EX-99.53 Miscellaneous Exhibit -- exhibit99-53 HTML 44K 55: EX-99.54 Miscellaneous Exhibit -- exhibit99-54 HTML 31K 56: EX-99.55 Miscellaneous Exhibit -- exhibit99-55 HTML 297K 57: EX-99.56 Miscellaneous Exhibit -- exhibit99-56 HTML 101K 58: EX-99.57 Miscellaneous Exhibit -- exhibit99-57 HTML 33K 59: EX-99.58 Miscellaneous Exhibit -- exhibit99-58 HTML 33K 60: EX-99.59 Miscellaneous Exhibit -- exhibit99-59 HTML 37K 7: EX-99.6 Miscellaneous Exhibit -- exhibit99-6 HTML 499K 61: EX-99.60 Miscellaneous Exhibit -- exhibit99-60 HTML 34K 62: EX-99.61 Miscellaneous Exhibit -- exhibit99-61 HTML 31K 63: EX-99.62 Miscellaneous Exhibit -- exhibit99-62 HTML 33K 64: EX-99.63 Miscellaneous Exhibit -- exhibit99-63 HTML 35K 65: EX-99.64 Miscellaneous Exhibit -- exhibit99-64 HTML 33K 66: EX-99.65 Miscellaneous Exhibit -- exhibit99-65 HTML 36K 67: EX-99.66 Miscellaneous Exhibit -- exhibit99-66 HTML 37K 68: EX-99.67 Miscellaneous Exhibit -- exhibit99-67 HTML 37K 69: EX-99.68 Miscellaneous Exhibit -- exhibit99-68 HTML 31K 70: EX-99.69 Miscellaneous Exhibit -- exhibit99-69 HTML 37K 8: EX-99.7 Miscellaneous Exhibit -- exhibit99-7 HTML 155K 71: EX-99.70 Miscellaneous Exhibit -- exhibit99-70 HTML 33K 72: EX-99.71 Miscellaneous Exhibit -- exhibit99-71 HTML 30K 73: EX-99.72 Miscellaneous Exhibit -- exhibit99-72 HTML 32K 74: EX-99.73 Miscellaneous Exhibit -- exhibit99-73 HTML 177K 75: EX-99.74 Miscellaneous Exhibit -- exhibit99-74 HTML 37K 76: EX-99.75 Miscellaneous Exhibit -- exhibit99-75 HTML 35K 77: EX-99.76 Miscellaneous Exhibit -- exhibit99-76 HTML 159K 78: EX-99.77 Miscellaneous Exhibit -- exhibit99-77 HTML 160K 79: EX-99.78 Miscellaneous Exhibit -- exhibit99-78 HTML 42K 80: EX-99.79 Miscellaneous Exhibit -- exhibit99-79 HTML 35K 9: EX-99.8 Miscellaneous Exhibit -- exhibit99-8 HTML 75K 81: EX-99.80 Miscellaneous Exhibit -- exhibit99-80 HTML 35K 82: EX-99.81 Miscellaneous Exhibit -- exhibit99-81 HTML 588K 83: EX-99.82 Miscellaneous Exhibit -- exhibit99-82 HTML 46K 84: EX-99.83 Miscellaneous Exhibit -- exhibit99-83 HTML 50K 85: EX-99.84 Miscellaneous Exhibit -- exhibit99-84 HTML 47K 86: EX-99.85 Miscellaneous Exhibit -- exhibit99-85 HTML 35K 87: EX-99.86 Miscellaneous Exhibit -- exhibit99-86 HTML 355K 88: EX-99.87 Miscellaneous Exhibit -- exhibit99-87 HTML 130K 89: EX-99.88 Miscellaneous Exhibit -- exhibit99-88 HTML 33K 90: EX-99.89 Miscellaneous Exhibit -- exhibit99-89 HTML 33K 10: EX-99.9 Miscellaneous Exhibit -- exhibit99-9 HTML 32K 91: EX-99.90 Miscellaneous Exhibit -- exhibit99-90 HTML 37K 92: EX-99.91 Miscellaneous Exhibit -- exhibit99-91 HTML 35K 93: EX-99.92 Miscellaneous Exhibit -- exhibit99-92 HTML 39K 94: EX-99.93 Miscellaneous Exhibit -- exhibit99-93 HTML 35K 95: EX-99.94 Miscellaneous Exhibit -- exhibit99-94 HTML 59K 96: EX-99.95 Miscellaneous Exhibit -- exhibit99-95 HTML 35K 97: EX-99.96 Miscellaneous Exhibit -- exhibit99-96 HTML 42K 98: EX-99.97 Miscellaneous Exhibit -- exhibit99-97 HTML 31K 99: EX-99.98 Miscellaneous Exhibit -- exhibit99-98 HTML 39K 100: EX-99.99 Miscellaneous Exhibit -- exhibit99-99 HTML 48K
| Cannex Capital Holdings Inc. - Exhibit 99.84 - Filed by newsfilecorp.com |
Form 62-103F3
REQUIRED DISCLOSURE BY AN ELIGIBLE INSTITUTIONAL INVESTOR
UNDER PART 4
State if the report is filed to amend information disclosed in an earlier report. Indicate the date of the report that is being amended.
This is an initial report.
Item 1 – Security and Reporting Issuer
1.1 State the designation of securities to which this report relates and the name and address of the head office of the issuer of the securities.
Cannex Capital Holdings Inc. (the “Issuer”)
1241
Alberni Street
Vancouver, British Columbia
V6E 4R4,
Canada
This report relates to:
| i. |
Senior secured convertible notes of the Issuer and its wholly owned indirect subsidiary Cannex Holdings (Nevada) Inc. (the “Convertible Notes”); and |
| ii. |
Common share purchase warrants of the Issuer (the “Warrants” and together with the Convertible Notes, the “Issuer Securities”). |
1.2 State the name of the market in which the transaction or other occurrence that triggered the requirement to file this report took place.
On November 21, 2018, the Issuer, a company listed on the Canadian Securities Exchange (the “CSE”) announced a US$32 million private placement investment (the “Principal Amount”) from Gotham Green Partners, LLC (the “Transaction”). The Transaction involved, among other things, the issuance of Convertible Notes with a maturity date of November 21, 2021. The Convertible Notes have a coupon of LIBOR +11% in Y1, LIBOR +10% in Y2 and LIBOR +9.5% in Y3 (the “Applicable Interest Rate”) with agreed voluntary prepayment rights after the first anniversary of the closing date. If the Convertible Notes are converted on or prior to October 31, 2019, they are convertible into Class A convertible restricted voting shares of the Issuer. If the Convertible Notes are converted after October 31, 2019, they are convertible into common shares of the Issuer.
Interest on the Convertible Notes shall accrue at the Applicable Interest Rate, of which 50% of the interest due at the end of each month shall be paid in cash in arrears and 50% of the interest due shall accrue and be added to the Principal Amount of the Convertible Notes, and such interest paid in kind shall be payable on the date that all remaining Principal Amount is due.
The Convertible Notes are exchangeable into shares of the Issuer at a price of US$0.83 per share. The Convertible Notes include warrants to purchase US$7 million in shares of the Issuer at US$1.00 per share, US$6 million in shares of the Issuer at US$1.33 per share, and US$4 million in shares of the Issuer at US$1.99 per share. All Warrants expire on November 21, 2021.
Item 2 – Identity of the Eligible Institutional Investor
2.1 State the name and address of the eligible institutional investor.
Gotham Green Partners, LLC (“GGP”)
Suite 29A, 489 5th
Avenue
New York, NY 10017
USA
2.2 State the date of the transaction or other occurrence that triggered the requirement to file this report and briefly describe the transaction or other occurrence.
The requirement to file this report was triggered on November 30, 2018, when GGP closed the Transaction and completed its acquisition of the Issuer Securities.
GGP acquired the following securities through the following funds: Gotham Green Fund 1, L.P.
This fund acquired:
Gotham Green Fund 1 (Q), L.P. This fund acquired:
Gotham Green Credit Partners SPV 2, L.P. This fund acquired:
2.3 State the name of any joint actors.
Gotham Green Fund 1, L.P., by its general partner, Gotham Green GP 1, LLC Gotham Green Fund 1 (Q), L.P., by its general partner, Gotham Green GP 1, LLC
Gotham Green Credit Partners SPV 2, L.P., by its general partner, Gotham Green Credit Partners GP 2, LLC
(collectively the “Funds”)
2.4 State that the eligible institutional investor is eligible to file reports under Part 4 in respect of the reporting issuer.
GGP is eligible to file reports under Part 4 of National Instrument 62-103 (“NI 62-103”) in respect of the Issuer.
Item 3 – Interest in Securities of the Reporting Issuer
3.1 State the designation and the net increase or decrease in the number or principal amount of securities, and in the eligible institutional investor’s securityholding percentage in the class of securities, since the last report filed by the eligible institutional investor under Part 4 or the early warning requirements.
GGP has not previously filed a report under Part 4 of NI 62-103 or the early warning requirements in respect of the Issuer’s securities.
3.2 State the designation and number or principal amount of securities and the eligible institutional investor’s securityholding percentage in the class of securities at the end of the month for which the report is made.
The Issuer disclosed in a securities purchase agreement (the “Securities Purchase Agreement”), dated November 21, 2018 that there were 87,192,204 common shares and 96,521,734 Class A common shares of the Issuer outstanding as of that date.
Assuming the conversion of the US$32,000,000 Principal Amount of Convertible Notes at US$0.83 per share to acquire 38,554,217 shares of the Issuer, and assuming the exercise of all 13,521,328 Warrants, GGP exercised control or direction over 52,075,545 shares of the Issuer, representing 22.0856% of the outstanding shares of the Issuer on a partially diluted basis as at November 30, 2018.
3.3 If the transaction involved a securities lending arrangement, state that fact.
The transaction did not involve a securities lending arrangement.
3.4 State the designation and number or principal amount of securities and the percentage of outstanding securities of the class of securities to which this report relates and over which
(a) the eligible institutional investor, either alone or together with any joint actors, has ownership and control,
GGP, together with the Funds as joint actors, has ownership and control over the Issuer Securities. See sections 1.2 and 2.2 for more information on the Transaction. See section 3.2 for the percentage of outstanding securities to which this report relates.
(b) the eligible institutional investor, either alone or together with any joint actors, has ownership but control is held by persons or companies other than the eligible institutional investor or any joint actor, and
N/A
(c) the eligible institutional investor, either alone or together with any joint actors, has exclusive or shared control but does not have ownership.
The Funds are the registered holders of the Issuer Securities, and GGP exercises direction and control over the Issuer Securities.
3.5 If the eligible institutional investor or any of its joint actors has an interest in, or right or obligation associated with, a related financial instrument involving a security of the class of securities in respect of which disclosure is required under this item, describe the material terms of the related financial instrument and its impact on the eligible institutional investor’s securityholdings.
N/A
3.6 If the eligible institutional investor or any of its joint actors is a party to a securities lending arrangement involving a security of the class of securities in respect of which disclosure is required under this item, describe the material terms of the arrangement including the duration of the arrangement, the number or principal amount of securities involved and any right to recall the securities or identical securities that have been transferred or lent under the arrangement.
State if the securities lending arrangement is subject to the exception provided in section 5.7 of NI 62-104.
N/A
3.7 If the eligible institutional investor or any of its joint actors is a party to an agreement, arrangement or understanding that has the effect of altering, directly or indirectly, the eligible institutional investor’s economic exposure to the security of the class of securities to which this report relates, describe the material terms of the agreement, arrangement or understanding.
N/A
INSTRUCTIONS
(i) “Related financial instrument” has the meaning ascribed to that term in NI 55-104. Item 3.5 encompasses disclosure of agreements, arrangements or understandings where the economic interest related to a security beneficially owned or controlled has been altered.
(ii) An eligible institutional investor may omit the securityholding percentage from a report if the change in percentage is less than 1% of the class.
(iii) For the purposes of Item 3.5, 3.6 and 3.7, a material term of an agreement, arrangement or understanding does not include the identity of the counterparty or proprietary or commercially sensitive information.
(iv) For the purposes of Item 3.7, any agreements, arrangements or understandings that have been disclosed under other items in this Form do not have to be disclosed under this item.
Item 4 – Purpose of the Transaction
State the purpose or purposes of the eligible institutional investor and any joint actors for the acquisition or disposition of securities of the reporting issuer. Describe any plans or future intentions which the eligible institutional investor and any joint actors may have which relate to or would result in any of the following:
The Issuer Securities were acquired in the ordinary course of business, for investment purposes only and not for the purpose of exercising control or direction over the Issuer.
(a) the acquisition of additional securities of the reporting issuer, or the disposition of securities of the issuer;
Depending on various factors, GGP and the Funds may in the future increase or decrease their ownership, control or direction over securities of the Issuer through open market transactions, private agreements or otherwise, and may transfer securities of the Issuer among affiliated funds.
(b) a sale or transfer of a material amount of the assets of the reporting issuer or any of its subsidiaries;
N/A
(c) a change in the board of directors or management of the reporting issuer, including any plans or intentions to change the number or term of directors or to fill any existing vacancy on the board;
N/A
(d) a material change in the present capitalization or dividend policy of the reporting issuer;
N/A
(e) a material change in the reporting issuer’s business or corporate structure;
N/A
(f) a change in the reporting issuer’s charter, bylaws or similar instruments or another action which might impede the acquisition of control of the reporting issuer by any person;
N/A
(g) a class of securities of the reporting issuer being delisted from, or ceasing to be authorized to be quoted on, a marketplace;
N/A
(h) the issuer ceasing to be a reporting issuer in any jurisdiction of Canada;
N/A
(i) a solicitation of proxies from securityholders;
N/A
(j) an action similar to any of those enumerated above.
N/A
Item 5 – Agreements, Arrangements, Commitments or Understandings With Respect to Securities of the Reporting Issuer
Describe the material terms of any agreements, arrangements, commitments or understandings between the eligible institutional investor and a joint actor and among those persons and any person with respect to securities of the class of securities to which this report relates, including but not limited to the transfer or the voting of any of the securities, finder’s fees, joint ventures, loan or option arrangements, puts or calls, guarantees of profits, division of profits or loss, or the giving or withholding of proxies. Include such information for any of the securities that are pledged or otherwise subject to a contingency, the occurrence of which would give another person voting power or investment power over such securities except that disclosure of standard default and similar provisions contained in loan agreements need not be included.
INSTRUCTIONS
(i) Agreements, arrangements or understandings that are described under Item 3 do not have to be disclosed under this item.
(ii) For the purposes of Item 5, the description of any agreements, arrangements, commitments or understandings does not include naming the persons with whom those agreements, arrangements, commitments or understandings have been entered into, or proprietary or commercially sensitive information.
Pursuant to the Securities Purchase Agreement between the Funds, the Issuer and Cannex Holdings (Nevada) Inc., the Issuer and Cannex Holdings (Nevada) Inc., issued the Convertible Notes and the Warrants. See sections 1.2 and 2.2 of this report for additional information on the Transaction.
If the Convertible Notes are converted on or prior to October 31, 2019, they are convertible into Class A convertible restricted voting shares of the Issuer. If the Convertible Notes are converted after October 31, 2019, they are convertible into common shares of the Issuer.
The payment and performance of the obligations of the Issuer contained in the Convertible Notes are secured by, among other things, (i) General Security Agreements with the Issuer and with Cannex Capital Group Inc., the Issuer’s wholly owned subsidiary, and (ii) a Guaranty and Pledge Agreement with the Issuer and Cannex Capital Group Inc., all dated November 21, 2018.
Item 6 – Change in Material Fact
If applicable, describe any change in a material fact set out in a previous report filed by the eligible institutional investor under the early warning requirements or Part 4 in respect of the reporting issuer’s securities.
N/A
Item 7 – Certification
The eligible institutional investor must certify that the information is true and complete in every respect. In the case of an agent, the certification is based on the agent’s best knowledge, information and belief but the eligible institutional investor is still responsible for ensuring that the information filed by the agent is true and complete.
This report must be signed by each person on whose behalf the report is filed or his authorized representative.
It is an offence to submit information that, in a material respect and at the time and in the light of the circumstances in which it is submitted, is misleading or untrue.
Certificate
The certificate must state the following:
I, as the eligible institutional investor, certify to the best of my knowledge, information and belief, that the statements made in this report are true and complete in every respect.
| December 10, 2018 | Date |
| “Jason Adler” | Signature |
| Jason Adler, Managing Member | Name / Title |
| This ‘40FR12G’ Filing | Date | Other Filings | ||
|---|---|---|---|---|
 | ||||
| 11/21/21 | None on these Dates | |||
| 10/31/19 | ||||
| Filed on: | 7/16/19 | |||
| 12/10/18 | ||||
| 11/30/18 | ||||
| 11/21/18 | ||||
| List all Filings | ||||